Amagma Therapeutics is Drug Discovery in United States that focus on developer business. Founded in 2019. They cover business area such as developer, antibody therapy, human disease, enzyme hyperactivity, overactive extracellular protease trigger tissue damage, clinician, efficacy, safety.
2019
( 5 years old in 2024 )
Developer
-
100 Beaver Street
Suite 307
Waltham, MA 02453
United States
Private
developerantibody therapyhuman diseaseenzyme hyperactivityoveractive extracellular protease trigger tissue damageclinicianefficacysafety
* We use standard office opening hours in near Amagma Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Amagma Therapeutics is Drug Discovery business from United States that founded in 2019 (5 years old in 2024), Amagma Therapeutics business is focusing on Developer.
Amagma Therapeutics headquarter office and corporate office address is located in 100 Beaver Street Suite 307 Waltham, MA 02453 United States.
Amagma Therapeutics was founded in United States.
In 2024, Amagma Therapeutics is currently focus on developer sector.
Above is snippet of Google Trends for "developer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Amagma Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
